| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2022 | Apr 7, 2022 | Nuvation Bio Inc. | 10% Owner | Sell | 15.0 | -2,500,000 | -10.89% | ✗ | $14M |
| Dec 15, 2021 | Dec 17, 2021 | Nuvation Bio Inc. | 10% Owner | Sell | 16.3 | -500,000 | -2.13% | ✗ | $5M |
| Dec 7, 2021 | Dec 9, 2021 | Nuvation Bio Inc. | 10% Owner | Sell | 15.0 | -1,400,000 | -5.63% | ✗ | $13.7M |
| Nov 22, 2021 | Nov 24, 2021 | Nuvation Bio Inc. | 10% Owner | Sell | 27.5 | -295,036 | -0.59% | ✗ | $2.9M |
| Nov 3, 2021 | Nov 5, 2021 | Nuvation Bio Inc. | 10% Owner | Sell | 15.0 | -2,000,000 | -7.37% | ✗ | $18.5M |
| Oct 28, 2021 | Nov 1, 2021 | Nuvation Bio Inc. | 10% Owner | Sell | 15.0 | -1,060,000 | -3.76% | ✗ | $10.2M |
| Sep 20, 2019 | Sep 23, 2019 | Gossamer Bio, Inc. | 10% Owner | Sell | 17.5 | -183,607 | -2.73% | ✗ | $4M |
| Sep 16, 2019 | Sep 18, 2019 | Gossamer Bio, Inc. | 10% Owner | Sell | 17.5 | -82,213 | -1.21% | ✗ | $1.8M |
| Sep 10, 2019 | Sep 12, 2019 | Gossamer Bio, Inc. | 10% Owner | Sell | 17.5 | -112,776 | -1.63% | ✗ | $2.4M |
| Sep 5, 2019 | Sep 9, 2019 | Gossamer Bio, Inc. | 10% Owner | Sell | 37.5 | -21,404 | -0.31% | ✗ | $461.5K |
| May 9, 2019 | May 13, 2019 | Trevi Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +481,000 | 82.59% | ✗ | $4.8M |